Exhibit 16.1
March 25, 2013
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
| Re: | Tamir Biotechnology, Inc. |
File No. 000-11088
Dear Sirs:
On March 25, 2013, we were informed that we were dismissed as the independent registered public accounting firm for Tamir Biotechnology, Inc. We have read the statements included under Item 4.01, Changes in Registrant’s Certifying Accountant, in the Form 8-K dated March 25, 2013, of Tamir Biotechnology, Inc. being filed with the Securities and Exchange Commission and are in agreement with the statements contained in the second and third paragraphs related to our firm. We have no basis to agree or disagree with other statements made therein.
/s/ CohnReznick LLP
CohnReznick LLP
Roseland, New Jersey